| GALDERMA GRP AG |
| Schweiz |
| Gesundheit |
| CH1335392721 / A407X6 |
| PY3 (Frankfurt) |
| FRA:PY3, ETR:PY3, PY3:GR |
| SMI |
| https://www.galderma.com/ |
|
Galderma Group AG is a global healthcare company focused exclusively on dermatology, providing science-based products and services across injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its injectable aesthetics portfolio..
>Volltext.. |
| 46045.35 Mio. EUR |
| 47664.83 Mio. EUR |
| 5270.45 Mio. EUR |
| 1270.38 Mio. EUR |
| 772.05 Mio. EUR |
| 3.3 EUR |
| 2450.25 Mio. EUR |
| 763.37 Mio. EUR |
| 1040.81 Mio. EUR |
| 0.39 |
| 17.22% |
| 111.47% |
| 0.38 EUR |
| 0.19% |
| 0.19% |
| 24.04.26 - 0.38052282€ |
| - |
| GALDERMA |
| 22.11.26 |
|
||||
|